Geode Capital Management LLC Has $6.66 Million Stake in Regencell Bioscience Holdings Limited $RGC

Geode Capital Management LLC lifted its holdings in Regencell Bioscience Holdings Limited (NASDAQ:RGC) by 5,637.5% during the 2nd quarter, Holdings Channel reports. The fund owned 391,066 shares of the company’s stock after acquiring an additional 384,250 shares during the quarter. Geode Capital Management LLC’s holdings in Regencell Bioscience were worth $6,664,000 at the end of the most recent reporting period.

Separately, Greenfield Savings Bank bought a new position in Regencell Bioscience in the 2nd quarter valued at $187,000. 0.13% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Regencell Bioscience in a report on Monday. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has an average rating of “Sell”.

Regencell Bioscience Trading Up 1.5%

RGC opened at $16.24 on Friday. The firm’s 50 day moving average is $15.00. Regencell Bioscience Holdings Limited has a one year low of $0.09 and a one year high of $83.60.

Regencell Bioscience Company Profile

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.